Details for Patent: 7,524,829

Title:	Antisense antiviral compounds and methods for treating a filovirus infection
Abstract:	The invention provides antisense antiviral compounds and methods of their use in inhibiting of growth of and treating infection by viruses of the Filoviridae family.
Inventor(s):	Stein; David A. (Corvallis, OR), Iversen; Patrick L. (Corvallis, OR), Bavari; Sina (Frederick, MD)
Assignee:	Avi BioPharma, Inc. (Corvallis, OR)
Filing Date:	Oct 31, 2005
Application Number:	11/264,444
Claims:	1. An antiviral composition for treating an Ebola virus infection, comprising: an antisense morpholino oligomer composed of morpholino subunits linked by phosphorous-containing intersubunit linkages which join a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit, wherein the oligomer comprises a targeting sequence which forms a heteroduplex with a target sequence within the AUG start site region of Ebola VP35 mRNA, and wherein the antisense oligomer inhibits virus production, wherein the antisense oligomer has at least 12 contiguous bases from a targeting sequence selected from the group consisting of SEQ ID NOS:21 -26. 2. The composition of claim 1, wherein the targeting sequence has the sequence of SEQ ID NO:21. 3. The composition of claim 1, wherein the targeting sequence has the sequence of SEQ ID NO:22.